Update on new biomaterials and their use in reconstructive surgery

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 4, 2003, Pages 240-244

  Pou, Anna M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE CEMENT; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; COLLAGEN; GROWTH FACTOR; HYALURONIC ACID; POLITEF;

BIOCOMPATIBILITY; BONE GRAFT; CRANIOFACIAL SURGERY; DEMINERALIZATION; EAR NOSE THROAT SURGERY; FIBROBLAST; HUMAN; IMPLANT; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION;

BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BONE TRANSPLANTATION; FACE; HUMANS; PROSTHESES AND IMPLANTS; RECONSTRUCTIVE SURGICAL PROCEDURES; REGENERATION; SKIN, ARTIFICIAL; SKULL; TISSUE ENGINEERING; WOUNDS AND INJURIES;

EID: 0038148073     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200308000-00004     Document Type: Review

References (30)

1. Truswell WH: Dual-porosity expanded polytetrafluoroethylene soft tissue implant: a new implant for facial soft tissue augmentation. Facial Plast Surg 2002, 4:92-97.
2. Costantino PD, Hiltzik D, et al.: Bone healing and bone substitutes. Facial Plast Surg 2002, 18:13-26. This article is an extensive review of all bone substitutes available, their composition, and current uses.
3. Parikh S: Bone graft substitutes: past, present, future. J Postgrad Med 2002, 48:142-148. This article reviews all aspects of available bone substitutes with emphasis on newly developed biomaterials.
4. Costantino PD, Hiltzik DH, Sen C, et al.: Sphenoethmoid cerebrospinal fluid lead repair with hydroxyapatite cement. Arch Otolaryngol Head Neck Surg 2001, 127:588-593.
5. Petruzzelli GJ, Stankiewicz JA: Frontal sinus obliteration with hydroxyapatite cement. Laryngoscope 2002, 112:32-38.
6. Baker SB, Weinzweig J, Kirschner RE, et al.: Applications of a new carbonated calcium phosphate bone cement: early experience in pediatric and adult craniofacial reconstruction. Plast Reconstr Surg 2002, 109:1789-1796.
7. Smith J, Gardner E, Dornhoffer J: Hearing results with a hydroxylapatite/titanium bell partial ossicular replacement prothesis. Laryngoscope 2002, 112:1796-1799.
8. Healos [Healos/MP52 web site]. 2003. Available at: http://orquest.com. Accessed April 29, 2003.
9. InFuse [InFuse web site]. 2003. Available at: http://www.medtronicsofamordanek.com Accessed April 29, 2003.
10. Jones I, Currie L, Martin R: A guide to biological skin substitutes. Br J Plast Surg 2002, 55:185-193. This article reviews all skin substitutes available, their composition and clinical applications.
11. Govindaraj S, Cohen M, Genden EM, et al.: The use of acellular dermis in the prevention of Frey's syndrome. Laryngoscope 2001, 111:1993-1998.
12. Lorenz RR, Dean RL, Hurley DB, et al.: Endoscopic reconstruction of anterior and middle cranial fossa defects using acellular dermal allograft. Laryngoscope 2003, 113:496-501.
13. Weber PC, Lambert PR, Cunningham CD, et al.: Use of alloderm in the neurologic setting. Am J Otolaryngol 2002, 23:148-152.
14. Sclafani AP, Romo T, Jacono AA, et al.: Evaluation of acellular dermal graft (AlloDerm) sheet for soft tissue augmentation: a 1-year follow-up of clinical observations and histological findings. Fac Plast Surg 2001, 3:101-103. This article discussed the longevity of Alloderm and Zyplast and compares the two.
15. Terino EO: Alloderm acellular dermal graft, applications in aesthetic soft-tissue augmentation. Clin Plast Surg 2001, 28:83-99.
16. Costantino PD, Govindaraj S, Hiltzik DH, et al.: Acellular dermis for facial soft tissue augmentation: preliminary report. Facil Plast Surg 2001, 3:38-43.
17. Gryskiewicz JM, Rohrich RJ, Reagan BJ: The use of alloderm for the correction of nasal contour deformities. Plast Reconstr Surg 2001, 107:561-570. This article discusses the long-term properties of Alloderm in nasal reconstruction.
18. Mansbridge J: Tissue-engineered skin substitutes. Expert Opin Biol Ther 2002, 2:25-34. This article discusses skin substitutes with emphasis on new advances in this area.
19. Forta Perm [Forta Perm web site]. 2003. Available at: http://www.organogenesis.com. Accessed April 29, 2003.
20. Forta Flex [Forta Flex web site]. 2003. Available at: http://fortaflex.com. Accessed April 29, 2003.
21. Cosmo derm and cosmo plast [Cosmo Derm web site]. 2003. Available at: http://www.inamed.com. Accessed April 29, 2003.
22. Fibrogen, Inc [Fibrogen, Inc web site]. 2003. Available at: http://fibrogen.com. Accessesd April 29, 2003.
23. Watson D, Keller G, Lacombe V, et al.: Autologous fibroblasts for treatment of facial rhytids and dermal depressions. Arch Plast Surg 1999, 1:165-170.
24. Cheng JT, Perkins SW, Hamilton MM: Office-based procedures in facial plastic surgery, collagen and injectable fillers. Otolaryngol Clin North Am 2002, 35:1-11. This is an excellent review of injectable materials for soft tissue augmentation. It discusses the advantages, disadvantages, longevity, and uses for each material.
25. Autologous fibroblasts [Isolagen web site]. 2003. Available at: http://isolagen.com. Accessed April 29, 2003.
26. Hertegard S, Hallén L, Laurent C, et al.: Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function. Laryngoscope 2002, 112:2211-2219.
27. Frenkiel S, Desrosiers MY, Nachtigal D: Use of hylan b gel as a wound dressing after endoscopic sinus surgery. J Otolaryngol 2002, 31 (suppl 1):541-544.
28. Sclafani AP, McCormick SA, Cocker R: Biophysical and microscopic analysis of homologous dermal and fascial materials for facial aesthetic and reconstructive uses. Facial Plast Surg 2002, 4:164-171.
29. Pearl AW, Woo P, Ostrowski R, et al.: A preliminary report on micronized alloderm injection laryngoplasty. Laryngoscope 2002, 112:990-996.
30. Lip Augmentation [lip Augmentation web site]. 2003. Available at: http://www.lipaugmentation.com. Accessed April 29, 2003. This web site is all inclusive. It discusses composition, longevity, FDA approval, cost, and applications of currently available and future injectable biomaterials.